探究胺碘酮治疗心衰合并心率失常患者的临床疗效

摘要

目的：探究胺碘酮治疗心脏衰竭合并心率失常患者的临床疗效。方法回顾性分析2014年11月至2015年9月在本院接受治疗的114例心衰合并心率失常患者的临床资料，依据治疗方式不同将其平均分为实验组和对照组，每组平均57例，实验组患者接受胺碘酮静脉注射+常规抗心衰治疗，对照组患者仅接受常规抗心衰治疗，分析两组患者的临床疗效和各项心脏功能指标改变情况。结果实验组患者的治疗总有效率（94.74%）明显高于对照组的治疗总有效率（85.97%），且他们之间的差异具有显著统计学意义（P<0.05）；两组患者的各项心功能指标均得到改善，其中实验组患者的改善程度明显优于对照组（P<0.05）。结论胺碘酮治疗心脏衰竭合并心率失常患者的临床疗效显著，且能显著改善患者的心脏功能，值得在后续的临床治疗中继续推广使用。%ABSTRAC:Objective To explore amiodarone treatment of heart failure combined rate of clinical efficacy in patients with abnormal heart rhythms.Methods A retrospective analysis of November 2014 - September 2015 in our hospital treated 114 cases of heart failure and abnormal heart rhythms in patients with clinical data, according to its different treatment were divided into experimental grouP57cases and control grouP(57cases), the experimental grouPreceived amine iodine one intravenous injection + conventional therapy, patients in the control grouPreceived only conventional therapy, clinical efficacy of the two groups of patients and the cardiac function parameters change the situation.Results The total efficiency of the treatment of patients (94.74%) was significantly higher than the total effective rate (85.97%) and the difference between them having a statistically significant (P<0.05); the two groups of patients cardiac function were improved, including the degree of improvement in patients in the experimental grouPthan the control grouP(P<0.05).Conclusion The clinical efficacy of amiodarone in the treatment of heart failure with arrhythmia patients was significantly, and can significantly improve a patient’s heart function, worth in subsequent clinical treatment continue to promote the use.